Moderna Gets FDA Approval For Updated COVID-19 Vaccines Targeting LP.8.1 Variant Of SARS-COV-2
RefinitivOkuma süresi: 1 dakikadan kısa
Moderna Inc 
MRNA:
MODERNA RECEIVES U.S. FDA APPROVAL FOR UPDATED COVID-19 VACCINES TARGETING LP.8.1 VARIANT OF SARS-COV-2
MODERNA: UPDATED FORMULA FOR SPIKEVAX IS NOW APPROVED FOR INDIVIDUALS 6 MONTHS THROUGH 64 YEARS OF AGE
MODERNA: MNEXSPIKE, CO'S NEW COVID-19 VACCINE, IS APPROVED FOR INDIVIDUALS 12 THROUGH 64 YEARS OF AGE
Bu haberi okumak için giriş yapın veya sonsuza kadar ücretsiz bir hesap oluşturun